Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: NZ$4.98 Billion

As of September 2024 Guardant Health has a market cap of NZ$4.98 Billion. This makes Guardant Health the world's 3559th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$4.98 B-3.9%
2023NZ$5.19 B18.31%
2022NZ$4.38 B-70.44%
2021NZ$14.84 B-17.13%
2020NZ$17.91 B64.69%
2019NZ$10.87 B126.46%
2018NZ$4.80 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Guardant Health was reported to be:

NZ$4.98 Billion
by Yahoo Finance info icon info icon
NZ$4.98 Billion
by CompaniesMarketCap info icon info icon
NZ$4.98 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$25.54 B 412.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.11 B 22.58%๐Ÿ‡บ๐Ÿ‡ธ USA